N.M. Admin. Code § 16.5.15.11

Current through Register Vol. 35, No. 21, November 5, 2024

Section 16.5.15.11 - ADMINISTRATION OF ENTERAL ANXIOLYSIS

A.Registration: No permit required. Enteral anxiolysis consist of the administration of a single dose enteral drug, not in combination with nitrous oxide or another drug, that does not exceed the normal therapeutic single dose of the drug recommended by the manufacturer in published literature. Anxiolytic drugs should be within the scope of practice and prescriptive authority of the practitioner. Anxiolytic drugs are for the sole purpose of diminution of anxiety related to dental treatment.

B.Education/training: it is assumed that all dentists who have successfully completed a course of study at an accredited dental school have the education for this level of anxiolysis.

(1) The dentist must have an active current dental license, current drug enforcement administration (DEA) registration and current New Mexico controlled substances registration and be registered with the New Mexico board of pharmacy.

(2) Each dentist who administers or auxiliary who monitors enteral anxiolysis shall have current basic life support certification.

C.Facility/records: The dentist must have appropriate equipment to monitor vital signs and appropriate emergency equipment and drugs for the anxiolytic agent used.

(1) Records should reflect the dose and drug administered.

(2) Records should reflect how the patient was released from the office and if accompanied by a driver.

(3) All administration of anxiolytic drugs shall be under the indirect supervision or prescription of a dentist.

N.M. Admin. Code § 16.5.15.11

16.5.15.11 NMAC - Rp, 16.5.15.11 NMAC, 3-17-05, Amended and Renumbered from 16.34.5.10 from by New Mexico Register, Volume XXVI, Issue 22, November 30, 2015, eff. 12/16/2015, Adopted by New Mexico Register, Volume XXIX, Issue 05, March 13, 2018, eff. 3/18/2018, Adopted by New Mexico Register, Volume XXXIV, Issue 10, May 31, 2023, eff. 5/31/2023